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ABSTRACT 
 
Background: It is unclear whether weight change since young adulthood affects the risk of 
mortality due to cardiovascular disease (CVD). Here I investigated weight change since age 
20 in relation to the risk of CVD mortality. 
Methods: A total of 41,364 eligible Japanese men and women aged 40-79 years participated 
in the Ohsaki Cohort Study baseline survey in 1994. Hazard ratios (HRs) and 95% confidence 
intervals (CIs) for CVD mortality were calculated according to weight change since age 20 
(loss ≥10.0 kg and 5.0−9.9 kg, stable [±4.9 kg], gain 5.0−9.9 kg and ≥10.0 kg). 
Results: During 13.3 years of follow-up, 1,756 participants died of CVD. The association 
between weight change and CVD mortality was L-shaped in men and U-shaped in women; 
the multivariate HRs (95% CIs) for men with weight loss ≥10.0 kg was 1.52 (1.25-1.85), and 
that for women with weight loss ≥10.0 kg and weight gain ≥10.0 kg was 1.62 (1.25-2.11) and 
1.36 (1.09-1.69), respectively. Cross-classification analysis based on body mass index (BMI) 
at age 20 and weight change tended to be U-shaped association except for men whose BMI 
had been <25 kg/m
2
 at age 20, which was L-shaped. 
Conclusion: Weight loss since young adulthood was associated with excess risks of mortality 
due to CVD in men, while U-shaped relationships were observed for women.  
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INTRODUCTION 
 
Obesity is an established risk factor for cardiovascular disease (CVD) morbidity
1-3
 and 
mortality.
4-6
 In addition to a high body mass index (BMI), weight gain also adversely affects 
CVD risk.
7-10
 The effect of weight change on CVD mortality has been assessed in several 
studies, but the results have varied. Some studies have reported weight gain was associated 
with CVD mortality,
11, 12
 or that there was a U-shaped association,
13-15
 whereas others have 
shown that only weight loss was associated with CVD mortality.
16-20
  
These differences in results could have been partly attributable to differences in the age 
composition of the study participants, the life stage at which weight change occurred, the 
duration of the weight change, or the length of follow-up among the studies.
21
 The elevated 
mortality risk associated with recent weight loss due to antecedent disease, especially in 
studies of older populations or those with short follow-up periods may easily lead to biased 
results. Monitoring long-term weight change, which represents the transition of weight 
trajectories during the course of life, may help to clarify the mixed results for CVD mortality 
among older populations.
22
 In previous Ohsaki Cohort Study, Shimazu et el. studied the 
association between an increase in BMI since age 20 and risk of all-cause, CVD and cancer 
mortality.
23
 They observed that being persistently obese since early adulthood was associated 
with higher CVD mortality, and tended to be with higher CVD mortality in those who having 
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an increase in BMI category from normal to obese or from overweight to obese. However, 
there was no information about having a decrease in BMI category from overweight to normal 
or from obese to normal, where the association between weight loss and CVD mortality has 
not been clarified. 
 In another study among middle-aged Japanese individuals, an inverse relationship 
between weight change and CVD mortality were observed for men, whereas no significant 
association was observed for women.
19
 Previous study has suggested that the metabolic and 
health consequences of weight change may differ between men and women.
24
 Furthermore, 
sex differences in major cardiovascular risk factors have been pointed out as a substantial 
reason for the sex difference in CVD risk.
25-27
 For instance, smoking and 
hypercholesterolemia were associated with higher CVD risk in men than in women,
25
 whereas 
hypertension, diabetes, obesity were noted to have an important role in CVD risk in women 
than in men.
26, 27
 However, previous studies of the association between weight change and 
subsequent CVD morbidity or mortality were based mainly on men or composite results,
7-10, 
12-16
 whereas sex-specific studies have been few and their results inconsistent.
17-20
 
To our knowledge, no prospective study has reported the relationship between weight 
change since early adulthood and specific causes of CVD mortality including ischemic heart 
disease (IHD) and stroke. The objective of the present study was to investigate weight change 
since age 20 in relation to the risks of total CVD mortality and mortality due to individual 
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types of CVD, using data obtained from a large prospective population-based cohort study in 
Japan. Furthermore, in order to clarify whether weight loss in overweight persons or weight 
gain in underweight persons may or may not be beneficial for CVD mortality risk, BMI at age 
20 was used for cross-analysis. 
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METHODS 
 
Study population 
 
The present data were derived from the Ohsaki Cohort Study, whose study design has 
been described in detail previously.
28-31
 The subjects were all National Health Insurance 
(NHI) beneficiaries, aged 40-79 years, living in the catchment area of the Ohsaki Public 
Health Center, Miyagi Prefecture, north-east Japan. The Ohsaki Public Health Center is a 
local government agency that provides preventive health services to the residents of 14 
municipalities in Miyagi Prefecture. The NHI is a community-based health insurance system 
for farmers, the self-employed, pensioners, and their dependents. The study area is a typical 
rural area and the main industry is agriculture. Thirty-nine percent of men were farmers, 28% 
were self-employed, and 28% were retired. Among women, 31% were housewives, 25% were 
farmers, and 15% were self-employed.
29
 
A baseline survey regarding various lifestyle habits, body weight at study baseline, body 
weight at age 20 and past medical history was conducted during the period from October 
through December 1994. Trained survey personnel visited the subjects and informed them of 
the survey objectives, the fact that subjects were treated anonymously at data analysis stage, 
and their freedom to decline. The subjects were asked to complete the questionnaires by 
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themselves and return them to the same personnel member within a week. Return of the 
self-administered questionnaires signed by the participants was considered to imply their 
consent to participate in the study. In order to protect the subjects’ privacy, their personal 
names were deleted from all NHI Claims History files, Withdrawal History files, and the 
baseline data files in the subsequent follow-up record linkage. The study protocol was 
approved by the Ethics Committee of Tohoku University School of Medicine. 
Among the 54,996 eligible individuals, 52,029 (95%) responded to the questionnaires. 
Participants who withdrew from the NHI before 1 January 1995, the time when the 
prospective collection of data on NHI withdrawals began, were excluded (n=776). Thus, the 
study cohort comprised the remaining 51,253 participants. For the present analysis, 
participants who reported with histories of myocardial infarction or stroke (n=2,510) or 
cancer (n=1,638) were excluded. After further excluding participants for whom data were 
missing, or who showed extreme values for current height, current weight or weight at age 20 
(n=5,741), 41,364 subjects (men: 20,112, women: 21,252) were included in the present 
analysis. 
 
Classification of exposures 
 
The self-administered questionnaire included questions on current height at the baseline 
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(in centimeters), current weight at the baseline and recalled weight at age 20 (in kilograms). 
For the present analysis, weight change (in kilograms) was defined as the difference between 
current weight and recalled weight. The participants were categorized into five groups 
according to weight change since age 20 as: weight loss (≥10.0 kg, 5.0-9.9 kg), stable weight 
(±4.9 kg change), weight gain (5.0-9.9 kg, ≥10.0 kg). The choice of cut-off value as a 5kg 
change was based on previous studies about long-term weight change and CVD mortality,
11, 15, 
19
 and for easily understandable by general population when promoting healthy body weight. 
The values of BMI at the baseline and at age 20 were also calculated as current weight and 
recalled weight at age 20 divided by the square of current height (kg/m
2
), respectively. 
The self-reported current height and weight data were highly correlated with measured 
data (correlation coefficient: 0.96 for weight and 0.93 for height) in a subsample who received 
health examinations in 1995 (n=14,883), the year after the baseline survey.
30
 
 
Follow-up 
 
The primary endpoints for the present analysis were CVD mortality, including IHD and 
stroke mortality, occurring between 1 January 1995 and 31 March 2008. All participants were 
followed up for mortality and emigration by reviewing the NHI withdrawal history files. 
When a participant withdrew from the NHI system because of death, emigration or 
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employment, the date of and reason for withdrawal were coded in the NHI withdrawal history 
files. Because subsequent information on participants who withdrew from the NHI because of 
emigration or employment was unavailable, their follow-ups were discontinued. As of 31 
March 2008, the follow-up rate in the Ohsaki NHI Cohort Study was 85.2% (80.7% among 
non-deceased subjects). 
For all the decedents, the causes of death were investigated by reviewing the death 
certificates filed at Ohsaki Public Health Center with permission from the Ministry of Health, 
Labour, and Welfare, Japan. Causes of death were encoded by trained physicians in 
accordance with the International Classification of Diseases and Related Health Problems, the 
Tenth Revision [ICD-10], for total CVD (code Group I), IHD (codes I20-25), total stroke 
(codes I60-69), ischemic stroke (code I63), and hemorrhagic stroke (code I61). 
 
Statistical analysis 
 
The person-years of follow-up were calculated from 1 January 1995 to the date of death, 
withdrawal from the NHI, or 31 March 2008, whichever occurred first. Cox proportional 
hazards regression analysis was used to investigate the sex-specific hazard ratios (HRs) and 
95% confidence intervals (CIs) between weight change since age 20 and CVD mortality. 
The following variables were considered as potential confounders: age (in years), current 
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height (in centimeters), body weight at age 20 (in kilograms), educational levels (junior high 
school or less, high school and college or higher), baseline job status (employed and not 
employed), smoking status at age 20 (yes/no), smoking status at baseline (never smoked, 
smoked in the past, currently smoking <20 cigarettes/day and currently smoking ≥20 
cigarettes/day), alcohol consumption (never drank, drank in the past, currently drinking <45.6 
g ethanol/day and current drinking ≥45.6 g ethanol/day), time spent walking (≥1 hour/day and 
<1 hour/day). Both smoking and physical activity were anticipated to be associated with both 
CVD mortality and weight change, including long-term smoking habits since age 20. Body 
weight at age 20 was included to control for each subject’s initial value when assessing the 
association between weight change and CVD mortality. For women, menopausal status 
(yes/no), oral contraceptive uses (yes/no) and hormone replacement therapies (yes/no) were 
also considered as confounders. 
To assess whether the risk of CVD death associated with weight change differed between 
subjects who were underweight, normal weight and overweight, we cross-classified the 
participants into groups according to their BMI at age 20 [<22.5 kg/m
2
 (underweight), 
22.5-24.9 kg/m
2 
(normal weight), and ≥25.0 kg/m2 (overweight)], treating BMI 22.5-24.9 
kg/m
2
 at age 20 with subsequent stable weight as the reference group. Furthermore, we 
repeated the analysis after exclusion of deaths in the first 3 years of follow-up. In the present 
study, the participant’s age ranged from 40 to 79 years, where cohort effect may not be fully 
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controlled by adjusting age as a continuous variable. Therefore stratified analysis according to 
the age at study entry was performed (40-59 versus 60-69 and 70-79). Another stratified 
analysis was conducted according to smoking status at baseline (never-smokers versus former 
smokers and current smokers in men; never-smokers versus ever-smokers in women), because 
smokers tend to gain less weight or loss their weight which may result in under-estimation of 
the risks associated with weight gain and over-estimation of the risks associated with weight 
loss. The statistical evidence for the difference in effect between these subgroup participants 
was assessed by computing log-likelihood ratio tests of the interaction. All statistical analyses 
were performed using the SAS software package (version 9.2; SAS Institute, Inc., Cary, North 
Carolina, USA). 
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RESULTS 
 
In the present study population, the mean BMI at age 20 was 22.5 kg/m
2
 [standard 
deviation (SD): 2.8] and at study entry was 23.5 kg/m
2
 (SD: 3.0). The mean change in body 
weight from age 20 to study entry was a gain of 2.0 kg (SD: 8.8) in men and a gain of 3.3 kg 
(SD: 8.4) in women. 
The sex-specific baseline characteristics of participants according to the weight change 
categories are summarized in Table 1. The participants who had lost of ≥10.0 kg in weight 
were older, and were more likely to have hypertension and diabetes, to have been educated 
until age 15, to have been unemployed at the baseline, and to be current smokers. On the other 
hand, the participants who had gained of ≥10.0 kg in weight were more likely to be smokers 
at age 20, current drinkers, and to walk less than one hour a day. However, the proportions of 
current smokers and current drinkers among women were much lower than among men. 
During the 13.3 years of follow-up (451,081 person-years), 1,756 CVD deaths (1,017 men 
and 739 women) were documented, including 408 IHD deaths (253 men and 155 women) and 
790 stroke deaths (436 men and 354 women). Table 2 shows the multivariate-adjusted HRs 
for CVD mortality according to the weight change categories. In men, the 
multivariate-adjusted HR relative to stable weight group was 1.52 (1.25-1.85) for weight loss 
≥10.0 kg group and no significant risks were observed in the other weight change groups. In 
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women, the multivariate-adjusted HRs relative to stable weight group were 1.62 (1.25-2.11) 
for weight loss ≥10.0 kg group and 1.36 (1.09-1.69) for weight gain ≥10.0 kg group. Because 
nonlinear associations were observed between weight change and CVD mortality, linear trend 
analyses were tested for weight loss categories and weight gain categories separately, treating 
subjects with 0 kg change in weight as the reference group. In men, weight loss was 
significantly associated with CVD mortality (p for trend <0.0001) whereas weight gain was 
not (p for trend =0.74). In women, the risks of CVD mortality increased significantly with 
increasing categories of both weight loss (p for trend <0.0001) and weight gain (p for trend 
=0.0016). In summary, there were an L-shaped association in men and a U-shaped association 
in women between weight change and CVD mortality. 
The risk of IHD and stroke mortality showed trends similar to overall CVD mortality. In 
men, weight loss of ≥10.0 kg group had a significantly higher risk of death due to all forms of 
stroke (HR=1.38, 95% CI: 1.01-1.89) and ischemic stroke (HR=1.54, 95% CI: 1.00-2.37). A 
noticeably lower risk of IHD mortality was observed among men with weight gain ≥10.0 kg 
group (HR=0.59, 95% CI: 0.37-0.94). In women, the relationships tended to be U-shaped for 
IHD and stroke mortality. These excess risks of all CVD and IHD mortality related to weight 
loss were persistently observed even after exclusion of early deaths in the first 3 years of 
follow-up. 
Table 3 shows the baseline characteristics of participants according to the BMI at age 20 
  Page 13 
and weight change categories. In men, regardless of weight change, the participants whose 
BMI had been <22.5 kg/m
2
 at age 20 were more likely to be smokers at age 20, whereas those 
whose BMI had been ≥25 kg/m2 at age 20 were more likely to have hypertension and diabetes. 
Furthermore, regardless of BMI category at age 20, the participants who had lost of ≥10.0 kg 
in weight were older and more likely to have diabetes. In women, regardless of weight change, 
the participants whose BMI had been <22.5 kg/m
2
 at age 20 were more likely to be smokers at 
age 20, to be current smokers, and to be current drinkers. In contrast, those whose BMI had 
been ≥25 kg/m2 at age 20 were more likely to have hypertension, to have diabetes, and to have 
been educated until age 15. Furthermore, regardless of BMI category at age 20, the 
participants who had lost of ≥10.0 kg in weight were older and more likely to be current 
smoker, whereas those who had gain of ≥10.0 kg in weight were more likely to have 
hypertension. 
Table 4 shows the multivariate-adjusted HRs for CVD mortality according to BMI at age 
20 and weight change categories, treating subjects with a BMI of 22.5-24.9 kg/m
2
 at age 20 
and subsequent stable weight (±4.9 kg change) as the reference group. For those whose BMI 
had been less than 25 kg/m
2 
at age 20, an L shaped association in men and a U-shaped 
association in women between weight change and CVD mortality. For those whose BMI had 
been ≥25 kg/m2 at age 20, the associations tended to be U-shaped in both men and women; the 
multivariate HRs (95% CIs) for men were 1.50 (1.10-2.04) among the weight loss ≥10.0 kg 
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group and 1.83 (0.89-3.77) among the weight gain ≥10.0 kg group, while those for women 
were 1.86 (1.23-2.81) among the weight loss ≥10.0 kg group and 1.90 (0.93-3.89) among the 
weight gain ≥10.0 kg group. These excess risks of CVD mortality were persistently observed 
even after exclusion of early deaths in the first 3 years of follow-up. In summary, the 
association tended to be U-shaped except for men whose BMI had been <25 kg/m
2 
at age 20. 
However, the excess risks of CVD mortality for women whose BMI had been <22.5 kg/m
2 
at 
age 20 and lost their weight were greatly attenuated in never-smokers; the multivariate HRs 
(95% CIs) were 2.92 (1.35-6.31) among the weight loss ≥10.0 kg group and 1.88 (1.12-3.16) 
among the weight loss 5.0-9.9 kg group (HR3). 
Table 5 shows the associations between weight change and CVD mortality, after 
stratification by age at study entry (40-59 versus 60-69 and 70-79) and smoking status. For 
the participants aged 40-59, the higher risks of CVD mortality associated with weight loss for 
more than 10.0kg were same as for those aged 60-69 and 70-79, although not statistically 
significant because of the small number of deaths. The risks of CVD mortality among the 
weight loss ≥10.0 kg groups were not altered significantly by smoking habit. The multivariate 
HRs (95% CIs) for men were 1.67 (0.92-3.03) among never-smokers, 1.60 (1.10-2.33) among 
former smokers, and 1.52 (1.16-2.00) among current smokers; the interaction was not 
statistically significant (p=0.15). 
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DISCUSSION 
 
In this large population-based prospective study of Japanese men and women, it was 
observed that the associations between weight change and CVD mortality differed by gender. 
Weight loss since age 20 was associated with significantly higher risks of CVD mortality in 
both men and women. Weight gain of ≥10.0 kg was a predictor of CVD mortality in women, 
but not in men. In cross-classification analysis based on BMI at age 20 and weight change, the 
association tended to be U-shaped, except for men whose BMI had been <25 kg/m
2 
at age 20. 
These excess risks among the participants who had lost weight persisted after excluding 
deaths within 3 years of follow-up. 
Previous studies have recognized different association between weight change and CVD 
mortality according to the life stage at which weight change occurred, being L-shaped in 
studies examining middle-aged men,
16, 17, 19, 20
 and U-shaped in studies examining elderly 
populations.
14, 15
 Higher CVD mortality associated with weight loss might be a direct 
consequence of ill health
14, 16, 17
 or be confounded by smoking and changes in smoking habits 
since age 20. In the present study, the higher risks in subjects who had lost weight were 
persistently observed in the subgroup without self-reported histories of hypertension and 
diabetes mellitus at baseline (data not shown), or after exclusion of early deaths in the first 3 
years of follow-up. Furthermore, the higher risks of CVD mortality were not altered by 
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smoking status at age 20 or at baseline. Therefore, the excess risks of CVD mortality 
associated with weight loss could not be totally explained by preexisting disease or smoking 
status. However, some underlying but undetected preclinical conditions or past diseases not 
accounted for could be present for several years before their clinical manifestations, leading to 
reverse causation. Other pre-existing attributes of health status may lead to high risks of CVD 
mortality after disease occurrence, such as socioeconomic and nutritional status, were difficult 
to assess comprehensively. Furthermore, compared with underweight subjects, reduced 
fatality rates among aged overweight subjects experiencing a non-fatal cardiovascular event 
were observed previously.
32
 In the present study, BMI at study entry was low (men: 20.9 
kg/m
2
; women: 20.7 kg/m
2
) among those participants who had lost weight, while low BMI 
has also been reported as an unfavorable prognostic factor among Japanese patients with 
congestive heart failure
33
 or those who have undergone first coronary revascularization.
34
 The 
higher case-fatality rate among those subjects may be one possible reason for the excess risk 
of CVD mortality associated with weight loss. 
Several previous studies have observed positive association between weight gain and 
CVD incidence. In the Nurses’ Health Study, there was a dose-response relationship between 
the amount of weight gained since age 18 and the incidence of coronary heart disease (CAD) 
during 20 years of follow-up.
35
 A positive association between long-term weight gain since 
young adulthood and CAD incidence in men has also been shown in previous studies.
8-10
 In 
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the present study, the observed positive association between weight gain and CVD mortality 
in women was consistent with previous study, but not in men. The discrepancy may be 
explained by different endpoints with incidence or mortality. The outcome endpoint in this 
study was mortality rather than incidence may help to comprehend the knowledge about the 
association between weight change and CVD risk, because a certain risk factor could become 
a prognostic factor for better outcome after disease occurrence.
36
 
In men, the present study yielded mixed results among weight gain groups. The risks of 
CVD mortality among weight gain groups tended to be higher than those among stable weight 
groups, except for men who were older than 60 years at study entry or whose BMI at age 20 
had been less than 25 kg/m
2
. Older men who had gained their weight since young adulthood 
might receive a beneficial effect, or those who had not been overweight at age 20. In other 
words, weight gain appeared to be harmful to younger men, or those whose BMI had been 
≥25 kg/m2 at age 20. Furthermore, there was a noticeably lower risk of IHD mortality among 
men with a weight gain of ≥10.0 kg, the majority of whom had a mean BMI of 21.1 kg/m2 
(SD: 2.1)
 
at age 20. Previous studies examining the association between BMI in young adults 
and long-term risks of IHD showed that, compared with those of normal weight, young obese 
men had a higher cardiovascular morbidity.
37-39
 The risks among obese young adults persist 
independently of weight changes in later adulthood.
38
 A previous study also reported that high 
BMI in middle age may be the most important weight-related risk factor for IHD mortality in 
  Page 18 
old age,
15
 since atherosclerosis begins in the first decade of life, even though its clinical 
manifestations most often occur in the fifth decade and beyond.
40
 According to the National 
Health and Nutrition Survey conducted by the Ministry of Health, Labour, and Welfare, Japan, 
the prevalence of being overweight among men aged 20-29 has increased from 12% to 21% 
over the last 20 years,
41
 indicating that the unfavorable effect of weight gain might impose a 
substantial public health burden on Japan in the near future. 
In the present study, weight loss was significantly associated with all forms of stroke and 
ischemic stroke mortality in men, and all forms of stroke mortality in women. After exclusion 
of deaths in the first 3 years of follow-up, a higher risk of ischemic stroke mortality was 
observed among men with weight gain 5.0-9.9 kg group, and the risks of all forms of stroke 
mortality increased significantly with increasing categories of weight gain in women (p for 
trend <0.05). As for hemorrhagic stroke, the results were not easy to interpret because of the 
small number of deaths. The observed positive association between weight gain and stroke 
mortality was consistent with several previous studies, which examining stroke risks with 
weight change found increased incidence associated with long-term weight gain.
42, 43
 In Japan, 
Saito et al also reported that weight gain was significantly associated with higher risks of all 
forms of stroke and ischemic stroke events in Japanese women.
44
 However, the inconsistency 
between weight gain and stroke mortality in men may be contributed by another important 
risk factor – hypertension, which is reported to be the strongest risk factor for the 
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development of stroke.
3
 
The results of cross-classified analysis according to BMI at age 20 and weight change 
categories showed there was no effect modification by BMI at age 20 (p for interaction =0.17 
in men, 0.38 in women). Men and women whose BMI had been <22.5 kg/m
2 
at age 20 and 
then lost ≥10 kg in weight had the highest risk of CVD mortality. However, the excess risks of 
CVD mortality for women whose BMI had been <22.5 kg/m
2 
at age 20 and lost their weight 
were greatly attenuated in never-smokers, where smoking behavior may partly explain the 
high mortality risks of CVD in lean young adult with weight loss. Further research including 
the exact information about long-term smoking behavior change may help to complete the 
knowledge. 
In this study, it was observed that the associations between weight change and CVD 
mortality differed by gender (p=0.006 for interaction with sex), where weight gain was 
associated with a higher mortality in women but not in men. Few studies have examined 
sex-specific effects on the association between weight change and CVD mortality.
17, 19, 20
 In 
Norway, Drøyvold et al.
17
 reported that both men and women who lost weight had a higher 
CVD mortality than those who were weight-stable, whereas Wilsgaard et al.
20
 showed that 
weight loss was associated with excess mortality only in men. A previous study has suggested 
that weight change is associated with more relative changes in fat-free mass in men than in 
women,
24
 and body fat percentage has been reported as highly indicative of CVD risk factors 
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in another study.
45
 In other words, weight gain in women is associated with a higher degree of 
fat mass gain than is the case in men, possibly leading to unfavorable metabolic and health 
consequences. 
In Japanese women, Saito et al.
19
 reported that there was no significant association 
between weight change since age 20 and CVD mortality, although a U-shaped relationship 
was observed for women in the present study population. The difference may be explained by 
the age of the study population in Saito’s study, where the average age of women subjects was 
50 years. As most of the women participants in the Ohsaki Cohort Study were more than 60 
years old and thus post-menopausal, lacking of estrogen protection effect.
46
 Without estrogen 
protection effect, the risk of CVD greatly increases comparing with premenopausal women. 
Estrogen modifies endothelial function through two important mechanisms; one is the 
modulation of nitric oxide activity and the other is attenuation of vascular response to 
endothelial injury.
46
 Following menopause, the protection from endogenous estrogen is lost 
then endothelial dysfunction and atherosclerotic lesions active progression has been 
demonstrated.
47, 48
 Furthermore, decline in estrogen secretion after menopause is associated 
with an increase in abdominal fat, which is associated with an increase in CVD risk, and 
weight gain is usually accelerated at menopause.
49
 
This study had several strengths in addition to its prospective nature and high response 
rate. First, effects of several important confounding factors on weight change and CVD 
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mortality were assessed: smoking status at age 20 and baseline, alcohol drinking and physical 
activity. Subgroup analysis of smoking status was also conducted to clarify that there was no 
interaction between smoking and weight loss with CVD mortality. Second, to our knowledge, 
this is the first reported study to have examined the association of weight change since young 
adulthood with specific causes of CVD mortality. 
Several limitations should also be noted. First, the body weight values at age 20 were based 
on recall and could not be validated in the present study population. However the accuracy of 
long-term recall of previous body weight has been verified in a study involving middle-aged 
Japanese, and that had indicated high correlations (r=0.85).
50
 Regarding the validity of 
self-reported past body weight in the elderly population, previous studies showed that persons 
with a higher current BMI tended to underestimate their past weight, whereas those with a 
lower current BMI tended to overestimate their past weight.
51, 52
 This potential for 
overestimation of weight change may have weakened, but not substantially distorted the 
association between weight change and risk of CVD mortality in the present study. Second, 
information about weight was only available at two time points: age 20 and study entry, and 
there was no information about whether any weight loss was intentional or unintentional. 
There are lots of body weight determinants which are also associated with CVD risks, such as 
diet, physical activity and smoking.
53-55
 Furthermore, those in the lost-weight categories might 
have gained more weight at some time during adulthood because of weight determinants 
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related behavior change. Since long-term weight change is an indicator of long-term energy 
balance, while negative energy balance could occur as a result of high expenditure such as a 
debilitating condition or low calorie intake such as that associated with dieting, the present 
findings should not be interpreted as evidence against the benefit of intentional weight 
reduction. Third, the validity of causes of death information based on death certificates, which 
were encoded by trained physicians, was somewhat limited. Possible misclassification should 
be noted because causes of death encoded as heart failure (codes I50) or cardiac arrest (codes 
I46) may be contaminated by cases of death due to other underlying diseases.
56
 However, the 
association between weight change and the risk of CVD mortality did not alter even when 
those deceased subjects were omitted. Forth, since lifestyle data were obtained through a 
one-time questionnaire, some residual confounders such as debilitating disease or other 
pre-existing attributes of health status which were not assessed in the baseline survey, may 
contribute to the higher risks of CVD mortality associated with weight loss. 
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CONCLUSION 
 
Weight loss since young adulthood was found to be associated with excess risks of CVD 
mortality in both men and women. Long-term weight gain was noted to be a risk factor for 
CVD death, especially in women. Men and women whose BMI had been <22.5 kg/m
2 
at age 
20 and then lost ≥10 kg in weight had the highest risk of CVD mortality, but it was partly 
explained by smoking behavior. These results suggest that if healthy lean young people 
maintain a stable weight, and overweight young people do not gain weight as they age, then 
the risk of mortality due to CVD may be reduced. 
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 Table 1. Characteristics of participants according to weight change since age 20 
Stable
Variables ≥10.0 kg 5.0-9.9 kg ±4.9 kg 5.0-9.9 kg ≥10.0 kg P-value
Men (n=20,112)
Number of subjects 1609 3117 7578 3880 3928
Age, years (SD) 66.9 (8.3) 63.9 (9.0) 58.2 (10.4) 56.2 (10.2) 55.4 (9.9) <.0001
BMI, kg/m
2
 (SD) at age 20 26.1 (4.1) 24.2 (2.4) 22.5 (2.1) 21.7 (2.0) 21.1 (2.1) <.0001
BMI, kg/m
2
 (SD) at baseline 20.9 (2.7) 21.8 (2.3) 22.4 (2.1) 24.2 (2.0) 26.3 (2.4) <.0001
Weight at age 20, mean (SD) 68.4 (11.8) 62.9 (7.0) 59.2 (6.4) 58.5 (6.4) 57.5 (6.9) <.0001
Weight at baseline, mean (SD) 54.8 (8.3) 56.8 (7.0) 59.1 (6.5) 65.0 (6.5) 71.8 (7.8) <.0001
Hypertenion (%) 28.3 24.3 20.2 22.6 26.7 <.0001
Diabetes mellitus (%) 12.7 8.7 5.1 7.0 7.0 <.0001
Education until age 15 (%) 72.5 72.1 60.6 54.9 52.8 <.0001
Unemployed at baseline (%) 32.8 22.9 16.3 15.7 13.7 <.0001
Smoker at age 20 (%) 35.4 37.3 41.3 42.3 42.3 <.0001
Current smoker (%) 62.5 60.3 59.3 51.7 49.3 <.0001
Current drinker (%) 63.0 69.7 75.4 75.0 76.7 <.0001
Walking <1 hour/day (%) 52.6 48.1 47.4 55.0 55.3 <.0001
Women (n=21,252)
Number of subjects 1192 2822 7417 4865 4956
Age, years (SD) 67.0 (9.1) 63.7 (9.7) 59.2 (10.0) 58.5 (9.5) 58.7 (9.3) <.0001
BMI, kg/m
2
 (SD) at age 20 26.5 (3.9) 24.4 (2.7) 22.4 (2.5) 21.5 (2.2) 20.7 (2.3) <.0001
BMI, kg/m
2
 (SD) at baseline 20.7 (2.8) 21.6 (2.6) 22.5 (2.4) 24.4 (2.3) 26.9 (2.7) <.0001
Weight at age 20, mean (SD) 59.2 (8.9) 54.9 (6.1) 51.2 (5.7) 49.5 (5.4) 48.2 (5.7) <.0001
Weight at baseline, mean (SD) 46.3 (6.6) 48.6 (6.1) 51.4 (5.7) 56.1 (5.5) 62.5 (6.6) <.0001
Hypertenion (%) 26.9 26.1 22.4 26.5 36.1 <.0001
Diabetes mellitus (%) 8.0 6.2 4.5 4.3 5.7 <.0001
Education until age 15 (%) 68.7 62.0 52.8 53.7 56.3 <.0001
Unemployed at baseline (%) 61.4 57.2 46.2 48.5 51.6 <.0001
Smoker at age 20 (%) 1.5 1.4 1.4 1.3 1.8 <.0001
Current smoker (%) 14.1 8.8 8.5 7.2 9.7 <.0001
Current drinker (%) 18.8 20.6 23.0 24.6 26.5 <.0001
Walking <1 hour/day (%) 58.1 56.4 55.0 57.2 60.4 <.0001
BMI = body mass index; SD = standard deviation.
Weight change since age 20
Loss Gain
 
 Table 2. Hazard Ratio (HR) for cardiovascular disease mortality according to weight change 
since age 20 
Stable
Variables ≥10.0 kg 5.0-9.9 kg ±4.9 kg 5.0-9.9 kg ≥10.0 kg
Men (n=20,112) Person-years 14,652 31,798 83,070 43,485 44,506
All CVD No. of death 189 211 345 139 133
HR1
 
(95% CI)
§
  1.52 (1.25-1.85)
‡ 1.04 (0.87-1.24) 1 (reference) 0.95 (0.78-1.16) 0.99 (0.80-1.21)
HR2
 
(95% CI)
§
  1.36 (1.08-1.70)
† 0.99 (0.81-1.20) 1 (reference) 0.97 (0.78-1.21) 0.96 (0.76-1.20)
  IHD No. of death 45 49 97 39 23
HR1
 
(95% CI)
§ 1.41 (0.95-2.10) 0.92 (0.64-1.31) 1 (reference) 0.92 (0.63-1.35)  0.59 (0.37-0.94)
*
HR2
 
(95% CI)
§ 1.27 (0.80-1.99) 0.79 (0.52-1.18) 1 (reference) 0.86 (0.57-1.31)  0.54 (0.32-0.92)
*
  All Strokes No. of death 74 83 148 68 63
HR1
 
(95% CI)
§
  1.38 (1.01-1.89)
* 0.96 (0.73-1.26) 1 (reference) 1.08 (0.81-1.45) 1.08 (0.80-1.47)
HR2
 
(95% CI)
§ 1.24 (0.86-1.78) 0.96 (0.70-1.30) 1 (reference) 1.19 (0.87-1.63) 1.03 (0.73-1.45)
    Ischemic stroke No. of death 43 38 65 35 30
HR1
 
(95% CI)
§
  1.54 (1.00-2.37)
* 0.90 (0.60-1.36) 1 (reference) 1.34 (0.88-2.04) 1.25 (0.80-1.96)
HR2
 
(95% CI)
§ 1.24 (0.74-2.06) 0.85 (0.54-1.35) 1 (reference)  1.56 (1.00-2.41)
* 1.16 (0.70-1.91)
    Hemorrhagic stroke No. of death 15 20 49 15 17
HR1
 
(95% CI)
§ 1.16 (0.61-2.21) 0.84 (0.49-1.44) 1 (reference) 0.66 (0.37-1.18) 0.78 (0.44-1.39)
HR2
 
(95% CI)
§ 0.91 (0.39-2.10) 0.82 (0.43-1.56) 1 (reference) 0.66 (0.33-1.32) 0.87 (0.45-1.65)
Women (n=21,252) Person-years 12,266 30,175 82,206 53,797 55,126
All CVD No. of death 104 173 195 110 157
HR1
 
(95% CI)
§
  1.62 (1.25-2.11)
‡
  1.52 (1.23-1.88)
‡ 1 (reference) 0.98 (0.77-1.24)   1.36 (1.09-1.69)
†
HR2
 
(95% CI)
§
  1.48 (1.09-2.00)
*
  1.54 (1.21-1.95)
‡ 1 (reference) 1.08 (0.84-1.41)   1.48 (1.16-1.89)
†
  IHD No. of death 24 42 35 25 29
HR1
 
(95% CI)
§   1.98 (1.11-3.53)*   2.02 (1.27-3.22)
† 1 (reference) 1.24 (0.74-2.08) 1.39 (0.84-2.31)
HR2
 
(95% CI)
§
  1.92 (1.00-3.71)
*
  2.01 (1.20-3.39)
† 1 (reference) 1.31 (0.74-2.33) 1.29 (0.72-2.30)
  All Strokes No. of death 42 83 98 57 74
HR1
 
(95% CI)
§ 1.39 (0.93-2.07)   1.49 (1.10-2.01)
* 1 (reference) 0.99 (0.71-1.38) 1.24 (0.90-1.69)
HR2
 
(95% CI)
§ 1.28 (0.80-2.05)   1.71 (1.21-2.41)
† 1 (reference) 1.20 (0.83-1.73) 1.42 (0.99-2.03)
    Ischemic stroke No. of death 21 35 39 25 26
HR1
 
(95% CI)
§ 1.23 (0.68-2.22) 1.30 (0.81-2.08) 1 (reference) 1.19 (0.72-1.98) 1.21 (0.72-2.02)
HR2
 
(95% CI)
§ 0.97 (0.49-1.93) 1.41 (0.85-2.35) 1 (reference) 1.18 (0.67-2.08) 1.41 (0.81-2.44)
    Hemorrhagic stroke No. of death 7 29 15 11 20
HR1
 
(95% CI)
§ 1.00 (0.40-2.50) 1.43 (0.77-2.68) 1 (reference) 0.71 (0.35-1.46) 1.26 (0.68-2.33)
HR2
 
(95% CI)
§
   —
‖ 1.83 (0.88-3.81) 1 (reference) 1.21 (0.55-2.65) 1.70 (0.80-3.58)
*P  ≤ .05.
†
P  ≤ .01.
‡P  ≤ .001.
‖
Number of death was less then 3.
Weight change since age 20
Loss Gain
CI = confidence interval; CVD = cardiovascular disease; HR = hazard ratio; IHD = ischemic heart disease.
§
HR1 adjusted for age (in years), current height (in centimeters), body weight at age 20 (in kilograms), education (junior high school or less, high school,
and college or higher), baseline job status (employed and unemployed), smoking status at age 20 (yes/no), smoking status at baseline (never smoked,
smoked in the past, currently smoking <20 cigarettes/day and currently smoking ≥20 cigarettes/day), alcohol consumption (never drank, drank in the
past, currently drinking <45.6 g ethanol/day and current drinking ≥45.6 g ethanol/day), t ime spent walking (≥1 hour/day and <1 hour/day); women plus
manopausal status (yes/no), oral contraceptive use (yes/no) and hormone replacement therapy (yes/no); HR2 excluded from HR1 the participants who
died within the 3 years after baseline.
 
 
 Table 3. Characteristics of participants according to weight change since age 20, by BMI at age 20 
BMI at age 20
Stable Stable Stable
Weight change since age 20 ≥10.0 kg 5.0-9.9 kg ±4.9 kg 5.0-9.9 kg ≥10.0 kg ≥10.0 kg 5.0-9.9 kg ±4.9 kg 5.0-9.9 kg ≥10.0 kg ≥10.0 kg 5.0-9.9 kg ±4.9 kg 5.0-9.9 kg ≥10.0 kg
Men (n=20,112)
Number of subjects 164 729 3981 2636 3044 512 1358 2794 1050 756 933 1030 803 194 128
Age, years (SD) 67.5 (8.5) 62.8 (9.9) 56.2 (10.5) 55.6 (10.2) 55.4 (10.0) 68.1 (7.7) 64.3 (8.5) 60.0 (9.9) 57.2 (10.3) 55.2 (9.8) 66.2 (8.6) 64.0 (8.8) 61.4 (9.9) 58.1 (10.2) 55.4 (9.9)
BMI, kg/m
2
 (SD) at age 20 21.5 (0.8) 21.3 (1.0) 20.9 (1.2) 20.7 (1.3) 20.2 (1.5) 23.9 (0.7) 23.8 (0.7) 23.6 (0.7) 23.4 (0.6) 23.5 (0.7) 28.2 (4.3) 26.8 (1.6) 26.5 (1.5) 26.4 (1.6) 26.2 (1.2)
BMI, kg/m
2
 (SD) at baseline 17.2 (1.0) 19.1 (1.1) 21.0 (1.4) 23.1 (1.4) 25.6 (2.1) 19.3 (1.2) 21.4 (0.9) 23.4 (1.2) 25.8 (0.8) 28.5 (1.7) 22.4 (2.3) 24.3 (1.7) 26.0 (1.7) 28.8 (1.7) 31.1 (2.0)
Hypertenion (%) 21.3 18.2 16.2 20.5 25.2 23.4 23.5 23.4 26.8 32.7 32.3 29.7 28.4 29.9 27.3
Diabetes mellitus (%) 11.0 5.5 4.5 7.3 6.8 8.6 6.4 5.6 6.3 7.3 15.3 13.9 6.6 8.3 9.4
Education until age 15 (%) 63.5 67.6 55.9 52.5 51.7 75.5 74.1 65.2 59.6 57.1 72.4 72.6 68.1 62.8 53.5
Unemployed at baseline (%) 46.0 22.4 15.6 16.6 14.4 35.8 23.4 16.8 14.1 11.3 28.7 22.4 18.1 11.0 9.8
Smoker at age 20 (%) 37.2 42.3 43.9 43.2 42.8 35.0 35.8 39.4 41.4 40.5 35.3 35.7 34.5 34.0 39.1
Current smoker (%) 60.4 64.5 62.5 53.1 49.4 60.8 59.9 56.8 48.3 48.2 63.9 57.9 52.1 50.8 54.8
Current drinker (%) 58.2 67.5 76.2 74.9 77.5 60.8 69.6 75.3 75.6 74.7 65.1 71.3 71.6 73.4 69.6
Walking <1 hour/day (%) 64.0 51.1 48.4 55.1 55.6 50.0 45.9 45.5 56.0 53.9 52.0 48.7 48.7 48.0 56.9
Women (n=21,252)
Number of subjects 94 619 3973 3377 3931 316 1136 2440 1201 847 782 1067 1004 287 178
Age, years (SD) 67.6 (8.9) 63.2 (10.0) 57.6 (10.2) 57.6 (9.6) 58.6 (9.3) 66.3 (9.5) 62.2 (10.0) 60.3 (9.6) 60.1 (8.7) 59.1 (9.2) 67.3 (9.0) 65.6 (8.9) 63.2 (8.7) 62.8 (8.8) 61.2 (10.0)
BMI, kg/m
2
 (SD) at age 20 21.5 (0.9) 21.1 (1.1) 20.7 (1.3) 20.4 (1.4) 19.9 (1.6) 23.9 (0.7) 23.8 (0.7) 23.6 (0.7) 23.5 (0.7) 23.4 (0.7) 28.2 (3.7) 27.0 (1.9) 26.7 (1.8) 26.4 (1.4) 26.4 (1.4)
BMI, kg/m
2
 (SD) at baseline 16.9 (1.0) 18.5 (1.2) 21.0 (1.6) 23.3 (1.5) 26.1 (2.3) 18.8 (1.2) 21.0 (0.9) 23.4 (1.3) 26.3 (0.9) 29.3 (1.9) 21.9 (2.6) 24.1 (1.9) 26.1 (2.1) 29.2 (1.6) 32.5 (2.3)
Hypertenion (%) 22.3 19.1 17.3 22.7 34.5 17.1 21.5 26.4 33.6 41.4 31.3 35.0 33.1 41.1 44.9
Diabetes mellitus (%) 4.3 4.2 4.0 4.0 5.6 4.4 5.0 4.8 5.0 5.7 10.0 8.5 5.8 5.6 10.1
Education until age 15 (%) 67.4 55.5 46.6 49.5 54.5 65.4 60.8 56.0 61.4 61.4 70.3 67.2 69.9 71.3 72.1
Unemployed at baseline (%) 68.0 62.1 45.1 47.2 50.6 64.1 52.5 47.6 50.2 55.3 59.4 59.7 47.3 57.9 57.0
Smoker at age 20 (%) 2.1 2.6 2.1 1.6 1.9 1.3 1.1 0.6 0.6 1.3 1.5 1.0 0.9 0.7 1.1
Current smoker (%) 14.7 13.2 9.9 7.9 10.1 14.3 7.6 7.0 4.8 9.3 14.0 7.4 6.6 7.8 2.9
Current drinker (%) 16.7 20.1 25.3 25.7 27.9 15.7 21.8 21.2 22.8 21.0 20.3 19.7 18.2 18.5 20.8
Walking <1 hour/day (%) 71.1 62.7 55.5 56.7 60.3 57.7 52.3 53.7 56.6 61.1 56.7 57.2 56.7 66.2 60.3
BMI = body mass index; SD = standard deviation.
≥25.0 kg/m2
Loss Gain
<22.5 kg/m
2
Loss Gain
22.5-24.9 kg/m
2
Loss Gain
 
 Table 4. Hazard Ratio (HR) for CVD mortality according to weight change since age 20, by BMI at 
age 20 
Stable
≥10.0 kg 5.0-9.9 kg ±4.9 kg 5.0-9.9 kg ≥10.0 kg
Men (n=20,112)
<22.5 kg/m
2 No. of death 22 47 157 88 100
HR1
 
(95% CI)
§
  2.02 (1.27-3.20)
† 1.17 (0.83-1.65) 1.11 (0.86-1.43) 1.02 (0.76-1.37) 1.05 (0.78-1.41)
HR2
 
(95% CI)
§ 1.71 (0.98-2.97) 1.13 (0.77-1.66) 1.10 (0.83-1.45) 1.01 (0.73-1.40) 1.03 (0.74-1.43)
HR3
 
(95% CI)
§ — 0.81 (0.23-2.79) 1.16 (0.59-2.31) 0.82 (0.35-1.96) 1.61 (0.81-3.18)
22.5-24.9 kg/m
2 No. of death 68 91 132 39 25
HR1
 
(95% CI)
§
  1.84 (1.36-2.47)
‡ 1.11 (0.85-1.45) 1 (reference) 0.99 (0.69-1.41) 1.05 (0.69-1.62)
HR2
 
(95% CI)
§
  1.60 (1.13-2.26)
† 1.02 (0.75-1.38) 1 (reference) 1.05 (0.71-1.55) 0.97 (0.60-1.59)
HR3
 
(95% CI)
§ 2.04 (0.75-5.60) 0.82 (0.37-1.84) 1 (reference) 1.42 (0.61-3.29) 0.71 (0.21-2.42)
≥25.0 kg/m2 No. of death 99 73 56 12 8
HR1
 
(95% CI)
§
  1.50 (1.10-2.04)
† 1.14 (0.84-1.54)  1.32 (0.95-1.83) 1.48 (0.81-2.69) 1.83 (0.89-3.77)
HR2
 
(95% CI)
§
  1.53 (1.08-2.16)
* 1.24 (0.88-1.73)   1.49 (1.05-2.13)
* 1.67 (0.89-3.14) 1.43 (0.58-3.54)
HR3
 
(95% CI)
§ 2.01 (0.93-4.37) 1.09 (0.45-2.43) 1.26 (0.55-2.86) — 2.03 (0.46-9.00)
Women (n=21,252)
<22.5 kg/m
2 No. of death 16 39 101 67 115
HR1
 
(95% CI)
§
  4.32 (2.45-7.62)
‡
  2.18 (1.42-3.34)
‡
  1.49 (1.04-2.12)
* 1.25 (0.85-1.83)   1.70 (1.18-2.45)
†
HR2
 
(95% CI)
§
  4.04 (2.06-7.92)
‡
  2.29 (1.42-3.72)
‡
  1.55 (1.04-2.30)
* 1.51 (0.99-2.30)   1.91 (1.28-2.86)
†
HR3
 
(95% CI)
§
 2.92 (1.35-6.31)
‡
 1.88 (1.12-3.16)
† 1.34 (0.88-2.03) 1.16 (0.74-1.83)  1.71 (1.12-2.61)
†
22.5-24.9 kg/m
2 No. of death 19 56 54 27 33
HR1
 
(95% CI)
§ 1.68 (0.99-2.85)   1.84 (1.26-2.68)
† 1 (reference) 1.12 (0.70-1.77)   2.08 (1.35-3.21)
‡
HR2
 
(95% CI)
§ 1.40 (0.74-2.67)   1.83 (1.20-2.81)
† 1 (reference) 0.97 (0.56-1.68)   2.13 (1.30-3.47)
†
HR3
 
(95% CI)
§ 1.61 (0.86-3.02) 1.65 (1.05-2.60) 1 (reference) 1.15 (0.67-1.97)  2.20 (1.35-3.61)
‡
≥25.0 kg/m2 No. of death 69 78 40 16 9
HR1
 
(95% CI)
§
  1.86 (1.23-2.81)
†
  1.86 (1.27-2.71)
† 1.33 (0.86-2.05)   1.86 (1.05-3.30)
* 1.90 (0.93-3.89)
HR2
 
(95% CI)
§
  1.84 (1.16-2.93)
*
  2.01 (1.32-3.05)
† 1.40 (0.87-2.25)   2.32 (1.28-4.19)
†
  2.39 (1.15-4.97)
*
HR3
 
(95% CI)
§
 1.76 (1.06-2.93)
*
 1.84 (1.18-2.88)
† 1.28 (0.76-2.15) 1.55 (0.76-3.16) 1.99 (0.88-4.50)
*P  ≤ .05.
†
P  ≤ .01.
‡P  ≤ .001.
§
HR1 adjusted for age (in years), current height (in centimeters), body weight at age 20 (in kilograms), education (junior high school or less, high school, and
college or higher), baseline job status (employed and unemployed), smoking status at age 20 (yes/no), smoking status at baseline (never smoked, smoked in the
past, currently smoking <20 cigarettes/day and currently smoking ≥20 cigarettes/day), alcohol consumption (never drank, drank in the past, currently drinking
<45.6 g ethanol/day and current drinking ≥45.6 g ethanol/day), t ime spent walking (≥1 hour/day and <1 hour/day); women plus manopausal status (yes/no), oral
contraceptive use (yes/no) and hormone replacement therapy (yes/no)
§
HR2: excluded the participants who died within the 3 years after baseline (from HR1)
§
HR3: never-smokers (from HR1)
Weight change since age 20
Loss Gain
BMI at age 20
BMI = body mass index; CI = confidence interval; CVD = cardiovascular disease; HR = hazard ratio.
 Table 5. Hazard Ratio (HR) for all CVD mortality according to weight change since age 20, by age 
and smoking status at baseline 
Stable
Variables ≥10.0 kg 5.0-9.9 kg ±4.9 kg 5.0-9.9 kg ≥10.0 kg
Men (n=20,112)
Age
    40-59 No. of death 10 20 55 28 41
HR (95% CI)
§  1.85 (0.86-3.97) 1.37 (0.80-2.34) 1 (reference) 0.93 (0.59-1.48) 1.26 (0.83-1.91)
    60-69 No. of death 52 88 134 57 46
HR (95% CI)
§
  1.43 (1.00-2.04)
* 1.20 (0.91-1.58) 1 (reference) 0.93 (0.68-1.28) 0.83 (0.59-1.17)
    70-79 No. of death 127 103 156 54 46
HR (95% CI)
§
  1.49 (1.15-1.93)
† 0.85 (0.66-1.10) 1 (reference) 0.98 (0.72-1.35) 1.05 (0.74-1.47)
Smoking status at baseline
    Never No. of death 20 22 45 16 25
HR (95% CI)
§  1.67 (0.92-3.03) 0.83 (0.49-1.41) 1 (reference) 0.88 (0.49-1.58) 1.29 (0.78-2.14)
    Former No. of death 52 58 92 38 37
HR (95% CI)
§
  1.60 (1.10-2.33)
* 1.06 (0.76-1.49) 1 (reference) 0.82 (0.56-1.21) 0.77 (0.52-1.15)
    Current No. of death 101 118 187 75 67
HR (95% CI)
§
  1.52 (1.16-2.00)
† 1.09 (0.86-1.38) 1 (reference) 1.04 (0.79-1.36) 1.08 (0.81-1.45)
Women (n=21,252)
Age
    40-59 No. of death 3 13 19 17 19
HR (95% CI)
§  1.86 (0.50-6.85)   2.49 (1.19-5.22)
* 1 (reference) 1.28 (0.66-2.48)  1.16 (0.60-2.24)
    60-69 No. of death 18 48 61 43 67
HR (95% CI)
§
 1.94 (1.10-3.41)
*
  1.86 (1.26-2.75)
† 1 (reference) 1.04 (0.70-1.54)  1.57 (1.10-2.26)
*
    70-79 No. of death 83 112 115 50 71
HR (95% CI)
§
 1.41 (1.03-1.93)
* 1.27 (0.97-1.65) 1 (reference) 0.93 (0.67-1.30) 1.30 (0.95-1.76)
Smoking status at baseline
    Never No. of death 63 116 139 78 119
HR (95% CI)
§
  1.50 (1.08-2.08)
*
  1.48 (1.14-1.90)
† 1 (reference) 1.00 (0.75-1.32)   1.50 (1.17-1.94)
†
    Ever No. of death 18 16 20 11 9
HR (95% CI)
§ 1.83 (0.87-3.84) 1.31 (0.65-2.61) 1 (reference) 1.01 (0.48-2.12)  0.59 (0.26-1.33)
*P  ≤ .05.
†P  ≤ .01.
‡P  ≤ .001.
Weight change since age 20
Loss Gain
CI = confidence interval; CVD = cardiovascular disease; HR = hazard ratio.
§
HR adjusted for age (in years), current height (in centimeters), body weight at age 20 (in kilograms), education (junior high school or less, high
school, and college or higher), baseline job status (employed and unemployed), smoking status at age 20 (yes/no), smoking status at baseline (never
smoked, smoked in the past, currently smoking <20 cigarettes/day and currently smoking ≥20 cigarettes/day), alcohol consumption (never drank,
drank in the past, currently drinking <45.6 g ethanol/day and current drinking ≥45.6 g ethanol/day), t ime spent walking (≥1 hour/day and <1
hour/day); women plus manopausal status (yes/no), oral contraceptive use (yes/no) and hormone replacement therapy (yes/no).
 
